Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Return on Equity (2022 - 2025)

Envoy Medical's Return on Equity history spans 4 years, with the latest figure at 1.19% for Q3 2025.

  • For Q3 2025, Return on Equity fell 50.0% year-over-year to 1.19%; the TTM value through Sep 2025 reached 1.19%, down 50.0%, while the annual FY2024 figure was 1.95%, 98.0% up from the prior year.
  • Return on Equity for Q3 2025 was 1.19% at Envoy Medical, up from 0.79% in the prior quarter.
  • Across five years, Return on Equity topped out at 4.47% in Q1 2024 and bottomed at 9.91% in Q4 2023.
  • The 4-year median for Return on Equity is 0.88% (2025), against an average of 0.18%.
  • The largest annual shift saw Return on Equity tumbled -929bps in 2023 before it surged 1099bps in 2024.
  • A 4-year view of Return on Equity shows it stood at 0.62% in 2022, then crashed by -1491bps to 9.91% in 2023, then soared by 111bps to 1.07% in 2024, then increased by 11bps to 1.19% in 2025.
  • Per Business Quant, the three most recent readings for COCH's Return on Equity are 1.19% (Q3 2025), 0.79% (Q2 2025), and 0.96% (Q1 2025).